在胃肠道癌症中的组织居民记忆T细胞:预后意义和治疗影响
Hiromichi Sato1,2, Sikun Meng1, Tomoaki Hara1
1Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Yamadaoka 2-2, Suita 565-0871, Japan.
Biomedicines
|June 27, 2024
概括
组织内存T细胞 (Trm细胞) 对胃肠癌免疫力和患者生存至关重要. 了解Trm细胞为免疫疗法和个性化癌症治疗提供了新的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 胃肠道癌症对全球健康构成重大负担.
- 组织内存T细胞 (Trm细胞) 是非淋巴细胞组织中的关键免疫参与者.
- 瘤细胞影响瘤的进展,预后和免疫疗法反应.
研究的目的:
- 审查Trm细胞在胃肠道癌症中的特征和功能.
- 讨论Trm细胞对患者结果和治疗策略的影响.
- 探索Trm细胞在癌症免疫治疗中的治疗潜力.
主要方法:
- 对有关Trim细胞和胃肠道癌症的现有文献的综述.
- 在瘤微环境中分析Trm细胞功能.
- 综合关于Trm细胞作为预后标记物和治疗点的数据.
主要成果:
- 瘤细胞在外围组织中具有战略位置,影响瘤的进展.
- 瘤细胞作为预后标志物,与改善的患者存活率相关.
- 瘤微环境中Trm细胞的存在与免疫治疗反应有关.
结论:
- 在对胃肠道癌症的免疫反应中,Trm细胞起着至关重要的作用.
- 了解Trm细胞可以导致个性化和有效的癌症疗法.
- 细胞具有预防癌症,疫苗开发和治疗其他疾病的潜力.
相关概念视频
Cell-mediated Immune Responses
68.1K
Overview
68.1K
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510


